<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03483415</url>
  </required_header>
  <id_info>
    <org_study_id>2011-KAEK-25 2018/02-01</org_study_id>
    <nct_id>NCT03483415</nct_id>
  </id_info>
  <brief_title>Long Thoracic Nerve Blockade for Pain Treatment After Video-Assisted Thoracoscopic Surgery</brief_title>
  <official_title>Investigation of Analgesic Effect of Long Thoracic Nerve Blockade After VATS (Video-Assisted Thoracoscopic Surgery) Operation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bursa Yüksek İhtisas Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bursa Yüksek İhtisas Education and Research Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Video-assisted thoracoscopic surgery (VATS) provides an opportunity to penetrate the thoracic
      cavity by video through an incision into the chest wall and facilitate surgical operation of
      lung pathologies.Various regional methods of anesthesia are currently being used to achieve
      this goal.

      The aim of the study was to assess the effectiveness of Long thoracic nerve bloc on
      postoperative VATS analgesia.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomized, controlled, single-blind</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>morphine consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Visual Analog Scale was used for pain.Pain intensity was measured using 0-10 cm visual analogue scale (VAS). (0=no pain, 10=intolerable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effect (Hypotension)</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>side effect Hypotension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>additional analgesic use</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>additional analgesic use</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effect (Nausea and vomiting)</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Nausea and vomiting scale
1. Nausea and vomiting scale (nausea-vomiting scale (NVS): 1. No nausea is present, 2. Mild nausea is present. 3. Severe nausea is present. 4. Vomiting is present) In case of a NVS score of &gt;3, an anti-emetic drug was administered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effect (Ramsay Sedation Scale (RSS)</measure>
    <time_frame>Postoperative 24 hours</time_frame>
    <description>Ramsay Sedation Scale (Ramsay Sedation Scale (RSS) : 1. Anxiety, agitation are present; 2. Cooperated, awake; 3. Sedatized, response to commands; 4. Sleepy, immediately awoken by auditory stimulus or glabella tap; 5. Sleepy, deep response to auditory stimulus or glabella tap and 6. Sleepy, no response to auditory stimulus or glabella tap)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nerve Block</condition>
  <condition>Video-Assisted Thoracic Surgery</condition>
  <arm_group>
    <arm_group_label>Grup L</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV patient-controlled analgesia (PCA) morphine
+ Ultrasound guided Long thoracic nerve blockage with 5 ml % 0.25 bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group P</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV patient-controlled analgesia (PCA) morphine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine Sulfate</intervention_name>
    <description>Intravenous morphine infusion with PCA: Solution was concentration of 0.5 mg/mL. Loading dose of 1 mg, 0.5 mg of bolus dose and 20 min of locking time.</description>
    <arm_group_label>Grup L</arm_group_label>
    <arm_group_label>Group P</arm_group_label>
    <other_name>Morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Ultrasound guided Long thoracic nerve blockage with 5 ml % 0.25 bupivacaine</description>
    <arm_group_label>Grup L</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who were in the American Society of Anesthesiologists (ASA) I-III class and
             underwent video-assisted thoracoscopic surgery (VATS).

        Exclusion Criteria:

          -  Previous history of opioid use preoperatively,

          -  Allergy to local anesthetics,

          -  The presence of any systemic infection,

          -  Uncontrolled arterial hypertension,

          -  Uncontrolled diabetes mellitus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Korgün Ökmen, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>korgün Ökmen, M.D</last_name>
    <phone>+902242955000</phone>
    <email>korgunokmen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Burcu Metin Ökmen, M.D</last_name>
    <phone>+902242955000</phone>
    <email>burcumetinokmen@gmail.com</email>
  </overall_contact_backup>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2018</study_first_submitted>
  <study_first_submitted_qc>March 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2018</study_first_posted>
  <last_update_submitted>March 23, 2018</last_update_submitted>
  <last_update_submitted_qc>March 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bursa Yüksek İhtisas Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Korgün Ökmen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

